Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0023052; signaling | GO:0007271; synaptic transmission, cholinergic | 1.072E-11 | 2.594E-08 | CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 4.532E-08 | 6.167E-05 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 4.997E-07 | 6.045E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 6.647E-07 | 6.893E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 3.374E-06 | 2.099E-03 | CYP1A1, CYP1A2 |
BP | GO:0032501; multicellular organismal process | GO:0046541; saliva secretion | 5.621E-06 | 3.060E-03 | CHRM1, CHRM3 |
BP | GO:0008152; metabolic process | GO:0033013; tetrapyrrole metabolic process | 1.081E-05 | 5.117E-03 | ABCC1, CYP1A1, CYP1A2 |
BP | GO:0008152; metabolic process | GO:0050665; hydrogen peroxide biosynthetic process | 1.572E-05 | 6.864E-03 | CYP1A1, CYP1A2 |
BP | Unclassified; | GO:0003056; regulation of vascular smooth muscle contraction | 2.020E-05 | 7.997E-03 | CHRM1, CHRM3 |
BP | GO:0032501; multicellular organismal process | GO:0090257; regulation of muscle system process | 2.330E-05 | 8.989E-03 | CHRM1, CHRM2, CHRM3, LMNA |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.027E-05 | 5.993E-05 | CYP1A2; CYP1A1; CYP1B1 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.745E-03 | 1.092E-02 | CYP1A2 |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.316E-06 | 2.902E-05 | CYP1A2; CYP1A1; CYP1B1 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.154E-02 | 4.711E-02 | CYP1A2 |
hsa00760 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.154E-02 | 4.711E-02 | NT5E |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 1.063E-03 | 3.381E-03 | CYP1A2; CYP1A1 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.057E-05 | 1.028E-04 | CYP1A2; CYP1A1; CYP1B1 |
hsa04020 | Calcium signaling pathway_Homo sapiens_hsa04020 | 8.016E-06 | 5.611E-05 | CHRM2; CHRM3; CHRM1; CHRM5 |
hsa04024 | cAMP signaling pathway_Homo sapiens_hsa04024 | 4.042E-04 | 1.572E-03 | CHRM2; CHRM1; TSHR |
hsa04080 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 5.305E-10 | 1.857E-08 | CHRM2; CHRM3; CHRM1; CHRM4; CHRM5; TAAR1; TSHR |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Irritable bowel syndrome | A09, K58, K59.1 | CHRM1; CHRM1; CHRM4; CHRM4; CHRM5 |
C00-D49: Neoplasms | Overactive bladder disorder | C67, N32.81 | CHRM1; CHRM3; CHRM4 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CHRM4 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | CHRM1; CHRM5 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Depression | F30-F39 | CHRM4 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Dementia | F01-F07 | CHRM1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Amnesia | F04 | CHRM5 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Schizophrenia | F20 | CHRM1; CHRM1; CHRM1; CHRM5 |